Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.
Szadai L, Bartha A, Parada IP, Lakatos A, Pál D, Lengyel AS, de Almeida NP, Jánosi ÁJ, Nogueira F, Szeitz B, Doma V, Woldmar N, Guedes J, Ujfaludi Z, Pahi ZG, Pankotai T, Kim Y, Győrffy B, Baldetorp B, Welinder C, Szasz AM, Betancourt L, Gil J, Appelqvist R, Kwon HJ, Kárpáti S, Kuras M, Murillo JR, Németh IB, Malm J, Fenyö D, Pawłowski K, Horvatovich P, Wieslander E, Kemény LV, Domont G, MarkoVarga G, Sanchez A.
Szadai L, et al. Among authors: kemeny lv.
bioRxiv [Preprint]. 2024 May 4:2024.05.01.592032. doi: 10.1101/2024.05.01.592032.
bioRxiv. 2024.
PMID: 38746333
Free PMC article.
Preprint.